Overcoming Barriers

The multiple myeloma treatment landscape is shifting rapidly, driven by the emergence of novel immunotherapies and highly effective multi-drug combinations. Navigating these changes in a clinical setting requires close coordination across the oncology care team.

Oncology nurses play a pivotal role in identifying emotional distress and connecting patients with vital psychosocial support. Kelly Dyckman, LCSW, a clinical social worker with Haven for Healing Psychotherapy in Shrewsbury, New Jersey, who provides counseling at Mary’s Place by the Sea in Ocean Grove, New Jersey, highlights how nurse-led collaboration can reshape the patient care journey.

The FDA granted accelerated approval to vusolimogene oderparepvec-wtpg (Tudriqev) in combination with nivolumab (Opdivo) for adults with unresectable advanced cutaneous melanoma progressing on anti-PD-1 therapy. This approval marks the arrival of a first-in-class oncolytic immunotherapy, bringing both hope to patients and a shift in clinical practice for oncology nurses. According to Michael K.